Data collected included co-morbidities ( diabetes mellitus , hypertension , congestive heart failure ) , creatinine clearance ( CLCR ) , concomitant treatment with potentially nephrotoxic drugs , vancomycin trough concentrations , total daily dose , and duration of therapy .